Dermatologic agents during pregnancy and lactation: an update and clinical review

被引：39

作者：

Hale, EK ^{[1
]}

Pomeranz, MK ^{[1
]}

机构：

[1] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA

来源：

关键词：

D O I：

10.1046/j.1365-4362.2002.01464.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：197 / 203

页数：7

共 32 条

[1] *AM COLL OBST GYN, 1994, TECHN B AM COLL OBST, V193
[2] [Anonymous], 1999, MED LETT DRUGS THER, V41, P85
[3] Boothby LA, 2001, ANN PHARMACOTHER, V35, P1485
[4] BRANSKI D, 1986, J PEDIATR GASTR NUTR, V5, P316, DOI 10.1097/00005176-198605020-00028
[5] Briggs G., 1998, DRUGS PREGNANCY LACT, V5th
[6] Buck H W, 1998, Infect Dis Obstet Gynecol, V6, P49, DOI 10.1155/S106474499800012X
[7] EPIDEMIOLOGY OF ISOTRETINOIN EXPOSURE DURING PREGNANCY
DAI, WS
LABRAICO, JM
STERN, RS
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (04) : 599 - 606
[8] Prospective controlled study of hydroxyzine and cetirizine in pregnancy
Einarson, A
Bailey, B
Jung, G
Spizzirri, D
Baillie, M
Koren, G
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 78 (02) : 183 - 186
[9] COX-2-specific inhibitors -: the emergence of a new class of analgesic and anti-inflammatory drugs
Everts, B
Währborg, P
Hedner, T
[J]. CLINICAL RHEUMATOLOGY, 2000, 19 (05) : 331 - 343
[10] HARAHAP M, 1996, SKIN CHANGES DIS PRE, P321